How To Use Vagifem

Complete Step-by-Step Usage Guide, Dosage Instructions & Safety Information

Key Takeaways: Using Vagifem Correctly

  • Initial treatment: One tablet daily for the first 2 weeks.
  • Maintenance: One tablet twice a week, leaving 3–4 days between doses.
  • Application: Use the single‑use applicator; insert the tablet high into the vagina (8–10 cm).
  • When to stop: Contraindicated if you have breast cancer, unexplained bleeding, blood clots, or liver disease.
  • Special precautions: Stop 4–6 weeks before major surgery; not for use in pregnancy or breastfeeding.

Vagifem is a low‑dose oestrogen tablet inserted directly into the vagina to relieve menopausal symptoms like dryness and irritation. Using it correctly ensures the medicine works effectively while minimising any risk of side effects.

Important Medical Advice

Stop using Vagifem and seek immediate medical help if you develop: sudden chest pain or difficulty breathing (possible blood clot), painful swelling or redness in your legs, yellowing of skin or eyes (jaundice), severe headache or migraine‑like symptoms for the first time, or signs of an allergic reaction (swelling of face/tongue/throat, difficulty swallowing).

Step-by-Step Usage Guide

Vagifem is supplied with a disposable plastic applicator for each tablet. Follow these steps carefully:

  1. Prepare the tablet: Tear off one blister pack from the strip. Open the end of the blister by peeling the foil back – do not push the tablet through the foil.
  2. Load the applicator: Place the tablet into the cavity of the applicator barrel. Ensure it sits flat.
  3. Get into position: Stand with one foot raised on a stool, or lie on your back with knees bent and legs apart. Relax your pelvic muscles.
  4. Insert the applicator: Gently insert the applicator into the vagina as far as it will comfortably go (about 8–10 cm) until you feel slight resistance.
  5. Release the tablet: Press the plunger firmly until it clicks. This deposits the tablet high in the vagina. Withdraw the applicator carefully.
  6. Dispose of the applicator: Throw away the used applicator. Do not reuse. Wash your hands afterwards.

🗒️ Tip: The tablet will stick to the vaginal wall immediately and will not fall out when you stand or walk. A small amount of discharge is normal.

Dosage Guide: Starting and Maintenance Regimen

Your doctor will prescribe the lowest effective dose for the shortest duration necessary. The standard regimen is:

Initial Phase (first 2 weeks)

Insert one vaginal tablet every day. This builds up oestrogen levels in the vaginal tissues to reverse atrophy.

Maintenance Phase (from week 3 onwards)

Insert one tablet twice a week, leaving 3 or 4 days between doses. For example, use on Monday and Thursday, or Tuesday and Friday.

If you miss a dose during the initial daily phase, insert the tablet as soon as you remember. Do not double the dose. If you miss a maintenance dose, skip it and continue with your next scheduled dose. Treatment should be reviewed by your doctor at least once a year to ensure the benefit still outweighs the risks.

Who Should Use Vagifem

Vagifem is indicated for postmenopausal women who experience symptoms of vaginal atrophy, such as:

  • Vaginal dryness or itching
  • Painful intercourse (dyspareunia)
  • Irritation or soreness in the vaginal area
  • Urinary frequency or urgency due to urogenital atrophy

It is suitable for women who cannot take systemic HRT (oral or patch) because of the very low systemic absorption. The experience in treating women older than 65 years is limited, but no additional safety concerns have been identified.

Who Should Not Use Vagifem

Do not use Vagifem if any of the following apply to you. If you are unsure, speak to your doctor before starting treatment.

  • Allergy: Hypersensitivity to estradiol or any of the excipients (hypromellose, lactose monohydrate, maize starch, magnesium stearate, macrogol 6000).
  • Breast cancer: Current or past breast cancer, or suspected breast cancer.
  • Oestrogen‑sensitive cancer: Known or suspected cancer of the womb lining (endometrium) or any other oestrogen‑dependent malignancy.
  • Unexplained vaginal bleeding: Any bleeding not yet investigated by a doctor.
  • Endometrial hyperplasia: Excessive thickening of the womb lining that is not being treated.
  • Blood clots: History of venous thrombosis (e.g., deep vein thrombosis, pulmonary embolism) or a known clotting disorder (e.g., protein C, protein S, antithrombin deficiency).
  • Arterial disease: Recent or current heart attack, stroke, or angina.
  • Liver disease: Active liver disease or abnormal liver function tests that have not returned to normal.
  • Porphyria: A rare inherited blood disorder.

If any of these conditions appear for the first time while using Vagifem, stop treatment immediately and contact your doctor.

Vagifem and Food: Does It Matter?

Vagifem is inserted directly into the vagina, so it is not taken by mouth. Therefore, there is no interaction with food or drink. You do not need to take it with or without food. Simply follow the dosing schedule regardless of meals.

🗒️ Note: If you are using other vaginal preparations (creams, pessaries, etc.), leave a gap of several hours between treatments to avoid washing out the tablet or interfering with absorption.

Special Conditions: Pregnancy, Breastfeeding, Surgery

Pregnancy: Vagifem is for use in postmenopausal women only. If you become pregnant (unlikely during menopause), stop using it immediately and contact your doctor. It must not be used during pregnancy.

Breastfeeding: Vagifem is not recommended during breastfeeding. Small amounts of oestrogen may pass into breast milk, although the clinical significance is unknown. Discuss alternative non‑hormonal options with your doctor.

Surgery: If you are going to have elective surgery, tell your surgeon that you use Vagifem. You may need to stop using it about 4 to 6 weeks before the operation to reduce the risk of a blood clot. Your doctor will advise when it is safe to restart.

Other conditions: If you have any of the following, tell your doctor before using Vagifem, as they may require closer monitoring: epilepsy, diabetes, gallstones, high blood pressure, migraine, endometriosis, fibroids, systemic lupus erythematosus (SLE), otosclerosis, or a family history of breast cancer.

Vagifem FAQs

Vagifem is intended for postmenopausal women. If it is less than 12 months since your last period or you are under 50, you may still need contraception. Speak to your doctor for advice.

Ensure the tablet is fully seated in the applicator and that you press the plunger firmly until it clicks. If you cannot hear a click, the tablet may still have been released; check by withdrawing and inspecting the applicator.

Avoid inserting other vaginal products (creams, lubricants, pessaries) immediately before or after Vagifem. If you need to use them, leave a gap of at least 2–3 hours to prevent washing out the tablet.

Use the lowest effective dose for the shortest time. Many women use Vagifem long‑term for symptom control. Your doctor will review your treatment at least once a year.

Because Vagifem acts locally with very low systemic absorption, side effects like weight gain, mood changes, or breast tenderness are rare. If you experience them, consult your doctor.

Need Vagifem with Clear Usage Guidance?

If you are experiencing menopausal vaginal symptoms and think Vagifem may be right for you, a UK‑registered doctor can assess your suitability and provide a prescription after an online consultation.

Secure Prescription & Next‑Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors

Start Menopause Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 28 March 2026

Next Review: 28 September 2026

Published on: 28 March 2026

Last Updated: 28 March 2026